Alexion Pharmaceuticals, Inc.
Records under this name other than the patents Alexion Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 168 patents it holds.
Back to Alexion Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,587,233 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | In force | High confidence | |
| US 10,190,111 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | In force | High confidence | |
| US 10,954,503 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 9,109,046 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | In force | High confidence | |
| US 8,268,783 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · High confidence | In force | High confidence | |
| US 10,765,726 | Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 8,846,603 | NPP1 Fusion Proteins now held by Biomarin Pharmaceutical Inc. In force · High confidence | In force | High confidence | |
| US 9,540,621 | NPP1 Fusion Proteins now held by Biomarin Pharmaceutical Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,858,638 | Lysosomal Storage Disease Enzymes now held by Alexion Pharma LLC In force · High confidence | In force | High confidence | |
| US 8,455,439 | Antidotes for Factor Xa Inhibitors and Methods of Using the Same in Combination with Blood Coagulating Agents In force · Medium confidence | In force | Medium confidence |